Latest Insider Transactions at Prestige Consumer Healthcare Inc. (PBH)
This section provides a real-time view of insider transactions for Prestige Consumer Healthcare Inc. (PBH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Prestige Consumer Healthcare Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Prestige Consumer Healthcare Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 06
2024
|
John F. Kelly Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,202
+44.4%
|
-
|
Aug 06
2024
|
John E Byom Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,202
+4.03%
|
-
|
Aug 06
2024
|
Celeste A. Clark Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,202
+16.15%
|
-
|
Aug 05
2024
|
John F. Kelly Director |
BUY
Grant, award, or other acquisition
|
Direct |
555
+50.0%
|
-
|
May 07
2024
|
Ronald M. Lombardi Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,298
+4.26%
|
-
|
May 07
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
2,042
+9.78%
|
-
|
May 07
2024
|
William P'Pool Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,123
+9.71%
|
-
|
May 07
2024
|
Christine Sacco CFO & COO |
BUY
Grant, award, or other acquisition
|
Direct |
6,062
+16.75%
|
-
|
May 07
2024
|
Jeffrey Zerillo Senior VP Operations |
BUY
Grant, award, or other acquisition
|
Direct |
2,116
+4.85%
|
-
|
May 07
2024
|
Adel Mekhail EVP, Marketing & Sales |
BUY
Grant, award, or other acquisition
|
Direct |
3,020
+12.14%
|
-
|
May 06
2024
|
Christine Sacco CFO & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,363
-18.23%
|
$375,410
$70.0 P/Share
|
May 06
2024
|
Christine Sacco CFO & COO |
BUY
Grant, award, or other acquisition
|
Direct |
10,943
+27.11%
|
-
|
May 06
2024
|
Jeffrey Zerillo Senior VP Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,951
-4.72%
|
$136,570
$70.0 P/Share
|
May 06
2024
|
Jeffrey Zerillo Senior VP Operations |
BUY
Grant, award, or other acquisition
|
Direct |
3,894
+8.61%
|
-
|
May 06
2024
|
Ronald M. Lombardi Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
41,356
-11.88%
|
$2,894,920
$70.0 P/Share
|
May 06
2024
|
Ronald M. Lombardi Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
85,533
+99.59%
|
-
|
May 06
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
SELL
Payment of exercise price or tax liability
|
Direct |
1,597
-8.68%
|
$111,790
$70.0 P/Share
|
May 06
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
3,456
+15.82%
|
-
|
May 06
2024
|
Adel Mekhail EVP, Marketing & Sales |
SELL
Payment of exercise price or tax liability
|
Direct |
3,303
-14.91%
|
$231,210
$70.0 P/Share
|
May 06
2024
|
Adel Mekhail EVP, Marketing & Sales |
BUY
Grant, award, or other acquisition
|
Direct |
5,472
+19.81%
|
-
|
May 06
2024
|
William P'Pool Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,946
-10.21%
|
$206,220
$70.0 P/Share
|
May 06
2024
|
William P'Pool Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,737
+16.58%
|
-
|
May 03
2024
|
William P'Pool Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
642
-2.7%
|
$44,940
$70.0 P/Share
|
May 03
2024
|
Christine Sacco CFO & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,167
-5.94%
|
$81,690
$70.0 P/Share
|
May 03
2024
|
Jeffrey Zerillo Senior VP Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
425
-1.12%
|
$29,750
$70.0 P/Share
|
May 03
2024
|
Ronald M. Lombardi Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,000
-1.13%
|
$210,000
$70.0 P/Share
|
May 03
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
SELL
Payment of exercise price or tax liability
|
Direct |
348
-2.28%
|
$24,360
$70.0 P/Share
|
May 03
2024
|
Adel Mekhail EVP, Marketing & Sales |
SELL
Payment of exercise price or tax liability
|
Direct |
719
-4.13%
|
$50,330
$70.0 P/Share
|
May 02
2024
|
William P'Pool Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,144
-2.32%
|
$81,224
$71.26 P/Share
|
May 02
2024
|
Christine Sacco CFO & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,090
-4.93%
|
$148,390
$71.26 P/Share
|
May 02
2024
|
Jeffrey Zerillo Senior VP Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
784
-1.02%
|
$55,664
$71.26 P/Share
|
May 02
2024
|
Ronald M. Lombardi Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,080
-0.94%
|
$360,680
$71.26 P/Share
|
May 02
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
SELL
Payment of exercise price or tax liability
|
Direct |
652
-2.07%
|
$46,292
$71.26 P/Share
|
May 02
2024
|
Adel Mekhail EVP, Marketing & Sales |
SELL
Payment of exercise price or tax liability
|
Direct |
1,288
-3.51%
|
$91,448
$71.26 P/Share
|
Mar 01
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
SELL
Open market or private sale
|
Direct |
172
-0.54%
|
$12,040
$70.42 P/Share
|
Mar 01
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
BUY
Exercise of conversion of derivative security
|
Direct |
172
+0.53%
|
$7,396
$43.87 P/Share
|
Feb 28
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
SELL
Open market or private sale
|
Direct |
662
-2.03%
|
$46,340
$70.28 P/Share
|
Feb 28
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
BUY
Exercise of conversion of derivative security
|
Direct |
662
+1.99%
|
$28,466
$43.87 P/Share
|
Feb 27
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
SELL
Open market or private sale
|
Direct |
1
-0.01%
|
$70
$70.0 P/Share
|
Feb 27
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
BUY
Exercise of conversion of derivative security
|
Direct |
1
+0.01%
|
$57
$57.18 P/Share
|
Feb 26
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
SELL
Open market or private sale
|
Direct |
9,677
-23.28%
|
$677,390
$70.44 P/Share
|
Feb 26
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
BUY
Exercise of conversion of derivative security
|
Direct |
9,677
+18.9%
|
$416,111
$43.87 P/Share
|
Feb 23
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
SELL
Open market or private sale
|
Direct |
23
-0.07%
|
$1,610
$70.0 P/Share
|
Feb 23
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
BUY
Exercise of conversion of derivative security
|
Direct |
23
+0.07%
|
$989
$43.87 P/Share
|
Feb 15
2024
|
Adel Mekhail EVP, Marketing & Sales |
SELL
Open market or private sale
|
Direct |
15,549
-27.92%
|
$1,072,881
$69.15 P/Share
|
Feb 15
2024
|
Adel Mekhail EVP, Marketing & Sales |
BUY
Exercise of conversion of derivative security
|
Direct |
15,549
+21.32%
|
$544,215
$35.09 P/Share
|
Feb 14
2024
|
William P'Pool Officer |
SELL
Open market or private sale
|
Direct |
26,019
-34.28%
|
$1,743,273
$67.9 P/Share
|
Feb 14
2024
|
William P'Pool Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,019
+25.52%
|
$1,170,855
$45.02 P/Share
|
Feb 14
2024
|
Christine Sacco CFO & COO |
SELL
Open market or private sale
|
Direct |
30,019
-35.37%
|
$2,041,292
$68.25 P/Share
|
Feb 14
2024
|
Christine Sacco CFO & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,788
+34.76%
|
$718,852
$29.46 P/Share
|